about
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examplesGenome-wide association studies identify four ER negative-specific breast cancer risk lociGenome-wide association study identifies novel breast cancer susceptibility lociThe European mesothelioma epidemicDo MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.Consensus report of the 2015 Weinman International Conference on MesotheliomaBreast cancer susceptibility-A new look at an old modelLow-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsComprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancerLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairCandidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskOccupational, domestic and environmental mesothelioma risks in the British population: a case-control studyCross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesEstimating the asbestos-related lung cancer burden from mesothelioma mortalityPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseCarcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trialComparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trialCertified causes of death in patients with mesothelioma in South East England.Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.A mortality study among workers in an English asbestos factory.Cancers of the respiratory tract in mustard gas workers.An update of cancer mortality among chrysotile asbestos miners in Balangero, northern ItalyIdentification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases.A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerParent-of-origin-specific allelic associations among 106 genomic loci for age at menarcheBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
P50
Q24531993-22A7DB0B-0B22-49D8-BAEA-F5EF6D690755Q24569560-A761D375-573B-44E0-A7FD-D0BB77699749Q24569561-66CDE59F-9941-4E57-8057-03D9D113DC81Q24622610-466916F9-717B-4AB2-9D0B-EFE75F8404DDQ24645441-E26CD75A-755F-486D-9BCC-E9F7894A352FQ24650064-34CE45F5-B2C2-4C3A-87B3-91BE6B9BDEC0Q27851413-C0773322-8F97-4D2B-8F90-CCDC1E86BC34Q27908468-7CD03E67-FB42-4325-B9B1-10F10FC540DAQ28215038-3BF86FB1-A5D3-44C6-8C62-F4077D2B3140Q28215462-518FE1A4-3CEF-4AAA-BD5B-16875DEFF6C9Q28247491-7AFD310F-6B1B-4051-944B-591BAE6993CFQ28267893-82BA5D9D-7886-4370-9762-2BFBE597854CQ28385765-F1CA4E52-5B86-4A86-9777-2AB4852518A8Q28388292-AA7A4546-34E2-4B09-8EE5-3ECE65990F33Q28388475-95810CA5-C38C-4D59-94B9-B686A79FA3C0Q28388497-A29BCD0B-2F9D-4BF8-B1E8-FB55D6C99C11Q28396373-1A68EAE1-918C-4497-9FDB-DB2D612EF346Q28584533-FD2DF397-101A-4429-B69A-5724960832E8Q29416989-EA6FDEF7-A019-42A2-AB57-52A30A5736D3Q29417036-F5943535-7326-4D0C-B563-A9C635CB185BQ29619206-BFDD2B32-1A52-4B1D-B373-EAD03F2981F2Q30374367-2E20F141-F798-4E7B-84D7-8F3E5E445357Q30747351-A2730EBF-2D81-4643-86CF-56CF7EC03487Q31009526-EDF531E8-D8B4-4AA5-86F0-F0DA12D8407CQ31044179-4D8E623B-6261-4B8E-8A79-04C8F7579DFCQ31082788-C690884A-B56C-4020-801F-E07F783632E8Q31135861-DC771F45-BF44-48AD-A9F2-790A002E8878Q31151637-C5A67432-A992-4B43-B9BD-BFEBE21EC0BCQ33402650-09FA1C75-A294-46B5-80B0-8D2196767354Q33518244-364D6B85-22C3-428D-A631-74EF2CA8A238Q33573839-12762F18-B4DC-4FA2-AD9D-8226A431B69DQ33577275-2BBBC89A-5172-4930-82E0-2941F3496588Q33634113-D8FE9717-EB5E-4A4D-B125-BE828325F247Q34038964-7F8E1D91-4DCB-4293-B849-D90D1EECAEC2Q34057960-A4BB0262-EE86-40A0-AD4A-06CECD5AD24AQ34115258-AD18F4B4-1116-44BC-A49F-A322F0417B11Q34123806-97B6EB07-69C7-4AE9-AC23-3C9CDA7ECAE6Q34181322-EBDBBAE4-88B1-45FA-9737-7DDD97B18603Q34289136-D9E0B015-39FB-40D9-91FA-E28F23E96519Q34327945-01D66D9A-9457-4CEA-B68E-B23A76C5456F
P50
description
English statistician
@en
statisticus
@nl
name
Julian Peto
@ast
Julian Peto
@de
Julian Peto
@en
Julian Peto
@es
Julian Peto
@nl
Julian Peto
@pt
ジュリアン・ピート
@ja
type
label
Julian Peto
@ast
Julian Peto
@de
Julian Peto
@en
Julian Peto
@es
Julian Peto
@nl
Julian Peto
@pt
ジュリアン・ピート
@ja
prefLabel
Julian Peto
@ast
Julian Peto
@de
Julian Peto
@en
Julian Peto
@es
Julian Peto
@nl
Julian Peto
@pt
ジュリアン・ピート
@ja
P106
P214
P244
P1816
P21
P214
P244
P31
P3885
julian-peto
P463
P496
0000-0002-1685-8912
P735
P737
P7859
lccn-n85125424